Tag: Chemotherapy
AOI Gurugram introduces new chemotherapy protocol for inoperable tongue cancer
Innovative, personalized treatment leads to significant recovery for a 46-year-old patient with advanced tongue cancer
Polatuzumab offers new hope for DLBCL patients on World Lymphoma Day
The first FDA-approved DLBCL treatment in nearly 20 years, Polatuzumab shows results in reducing relapse and disease progression
Nimotuzumab boosts survival rates in head & neck cancer: Tata Memorial...
Phase III study shows significant improvement in 10-year survival rates with Nimotuzumab addition, offering new hope for patients
CŌRE Diagnostics partners with Digistain to bring Uk’s AI breast cancer...
Revolutionary AI-enabled solution aims to improve diagnostic accuracy and reduce unnecessary chemotherapy in South Asia
Roche gets FDA approval for Alecensa in early lung cancer
This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence
Narayana Health initiates phase II clinical trial of CAR-T
The modified cells called CAR-T cells circulate in patients' body and selectively kill the cancer cells. Unlike chemotherapy, this treatment is highly selective immunotherapy
IIT Guwahati scientists develop a strategy to deliver chemotherapeutic drugs specifically...
The developed approach would allow the development of drug carriers for chemotherapy with enhanced efficacy and negligible side effects
Leading oncologists call for greater adoption of tech innovations to improve...
At the event organized by Oncology Forum and Fortis Cancer Institute, Delhi NCR, global experts also emphasized on the need for collaborative efforts to bring globally acclaimed treatment solutions for patients suffering from cancer
Blood-based biomarkers for brain tumours identified
Researchers have identified potential blood-based biomarkers to predict disease progression and survival times in those with late-stage brain tumours..........................
Breast cancer treatment takes a big leap forward
A new study by the cancer research group at the Department of Biotechnology's Institute of Life Sciences (DBT-ILS) has resolved the mystery and promises to pave the way for developing better drugs for breast cancer................